| 2006 |
Ltv1 shuttles between nucleus and cytoplasm in a Crm1-dependent manner and contains a functional nuclear export sequence (NES) sufficient to direct export of an NLS-containing reporter. Ltv1 co-sediments with 43S/40S subunits and copurifies with late 43S particles. Loss of LTV1 reduces small subunit export as judged by altered distribution of 5'-ITS1 rRNA and RpS3. Genetic interaction was identified between LTV1 and YRB2 (a Ran-GTP/Crm1-binding protein), placing Ltv1 as an adapter linking nuclear export machinery to the small subunit. |
Sucrose gradient co-sedimentation, copurification, shuttling assay (heterokaryon/reporter), FISH/fluorescence localization, genetic interaction analysis |
Genetics |
High |
16888326
|
| 2004 |
Ltv1 physically interacts with Yar1 (an ankyrin-repeat protein) and RpS3 as part of a pre-40S complex. Loss of LTV1 results in reduced absolute numbers of 40S subunits and excess free 60S subunits, indicating a role in 40S subunit production. Overexpression of RPS3 does not suppress the ribosome biogenesis defect of Δltv1, distinguishing Ltv1's role from that of Yar1. |
Co-immunoprecipitation, polysome profiling, genetic suppression analysis |
Genetics |
Medium |
15611164
|
| 2010 |
Mutation or deletion of the putative NES in Ltv1 is strongly dominant negative; the dominant-negative mutant protein accumulates in the cytoplasm associated with pre-40S subunits, causes accumulation of 20S rRNA in the cytoplasm (detected by FISH), retains late biogenesis factor Tsr1 in the cytoplasm, and leads to nuclear retention of 40S markers (RpS2-GFP, RpS3-GFP). This places Ltv1 as required for cytoplasmic maturation of 40S subunits, with nuclear retention of pre-40S being a downstream consequence of failure to recycle factors. |
Dominant-negative mutagenesis, FISH, fluorescence microscopy (GFP-tagged ribosomal proteins), sucrose gradient sedimentation |
Genetics |
Medium |
20215468
|
| 2014 |
Ltv1 has a canonical leucine-rich NES at its extreme C-terminus that is both necessary for Crm1 interaction and for Ltv1 nuclear export. The C-terminus can functionally substitute for the NES of the 60S-export adapter Nmd3. However, deletion of the NES at endogenous levels complements slow growth and 40S biogenesis defects, suggesting Ltv1's export adapter function is fully redundant with other factors. Dominant-negative phenotype of NES-deleted Ltv1 overexpression is suppressed by co-overexpression of RpS3 and its chaperone Yar1, or by deleting the RpS3-binding site in Ltv1ΔNES, indicating that titration of RpS3 by excess nuclear Ltv1 is the deleterious mechanism. |
NES mutagenesis, Crm1 interaction assay, functional NES substitution, genetic suppression, overexpression complementation |
Genetics |
Medium |
25213169
|
| 2015 |
Hrr25 (yeast CK1δ/ε homolog) phosphorylates Ltv1, causing its release from nascent pre-40S subunits and allowing subunit maturation. Hrr25 inactivation or expression of a non-phosphorylatable Ltv1 variant blocked Ltv1 release in vitro and in vivo and prevented entry into the translation-like quality control cycle. Phosphomimetic Ltv1 variants rescued viability after Hrr25 depletion. Ltv1 knockdown in human breast cancer cells impaired apoptosis induced by CK1δ/ε inhibitors, establishing that the antiproliferative activity of these inhibitors is due at least in part to disruption of ribosome assembly. |
In vitro phosphorylation assay, non-phosphorylatable and phosphomimetic mutants, genetic rescue, siRNA knockdown in human cancer cells, cell viability assay |
The Journal of cell biology |
High |
25778921
|
| 2015 |
Drosophila LTV1 interacts with ribosomal protein S3 and co-purifies with free 40S ribosome subunits. LTV1 is required for 40S ribosome subunit synthesis and pre-rRNA processing. dMyc directly regulates LTV1 transcription and requires LTV1 to stimulate ribosome biogenesis; loss of LTV1 blocks dMyc-induced cell growth and endoreplication. |
Co-immunoprecipitation, sucrose gradient fractionation, pre-rRNA processing assay, dMyc ChIP/transcriptional reporter, genetic epistasis (loss-of-function) |
The Journal of biological chemistry |
Medium |
25858587
|
| 2018 |
Ltv1 facilitates the incorporation of Rps3, Rps10, and Asc1/RACK1 into the small ribosomal subunit head, as shown by structure probing and biochemistry. Ribosomes from Ltv1-deficient yeast have substoichiometric amounts of Rps10 and Asc1 and show defects in translational fidelity and ribosome-mediated RNA quality control. Breast cancer cells have reduced LTV1 levels and produce ribosomes lacking RPS3, RPS10, and RACK1, connecting the chaperone mechanism to cancer cell ribosome diversity. |
Yeast genetics (deletion), mass spectrometry (quantitative ribosome composition), rRNA structure probing, translational fidelity assay, comparative analysis of human cancer cell lines |
The Journal of cell biology |
High |
30348748
|
| 2022 |
A homozygous missense variant (c.503A>G, p.Asn168Ser) in LTV1 creates a new donor splice site, causing aberrant splicing and a premature termination codon in exon 6, as confirmed by minigene splicing assay in HEK293T cells and patient skin sample. This loss-of-function variant is linked to the LIPHAK ribosomopathy syndrome, establishing LTV1 as a disease gene in humans. |
Whole-genome sequencing, homozygosity mapping, minigene splicing assay (HEK293T and patient tissue) |
Human molecular genetics |
Medium |
34999892
|
| 2023 |
Ltv1 directly binds 5 out of 15 ribosomal proteins in the small subunit head and indirectly affects 4 additional RPs via conformational transitions it regulates in the nascent subunit. Ltv1 aids recruitment of some RPs via direct protein-protein interactions while simultaneously delaying the recruitment of other RPs, thereby controlling hierarchical RP assembly. Delayed RP binding also delays acquisition of RNA structure stabilized by those RPs. Ltv1 directly chaperones folding of the three-helix junction j34-35-38 in rRNA. The LIPHAK disease-associated mutation causes global defects in head assembly consistent with these roles. |
Yeast genetics, mass spectrometry, DMS chemical probing (rRNA structure), biochemical interaction assays, disease-mutant analysis |
PLoS genetics |
High |
37910572
|